(1)
Keen, R.; Pantin, J.; Savage, N.; Dainer, P. M. Treatment of Refractory Anemia With Ring Sideroblasts Associated With Marked Thrombocytosis With Lenalidomide in a Patient Testing Negative for 5q Deletion and JAK2 V617F and MPL W515K/L Mutations. Hematol Rep 2016, 8.